"The 11-member committee voted nearly unanimously in November that Biogen's drug should not be approved, citing inconclusive evidence that the drug was effective.
"The FDA on Monday gave the drug “accelerated approval,” based on evidence that it can reduce a likely contributor to Alzheimer’s, rather than proof of a clear benefit against the disease."
Aren't we on the third or fourth round of "likely contributor to Alzheimer's" that turns out not to provide significant benefits?
"The FDA on Monday gave the drug “accelerated approval,” based on evidence that it can reduce a likely contributor to Alzheimer’s, rather than proof of a clear benefit against the disease."
Aren't we on the third or fourth round of "likely contributor to Alzheimer's" that turns out not to provide significant benefits?